Paradigm Biopharmaceuticals stock | Price, analyst rating, price target & growth

Paradigm Biopharmace...

ASX:PAR

$ 0,23

$0,00 (0,00%)

0,23 $

$0,00 (0,00%)

End-of-day quote: 04/10/2026

Paradigm Biopharmaceuticals Stock Value

Analysts currently give ASX:PAR a rating of Buy.

Buy

Paradigm Biopharmaceuticals Company Info

EPS Growth 5Y

0,00%

Market Cap

$0,10 B

Long-Term Debt

$0,00 B

Quarterly earnings

05/27/2026

Dividend

$0,00

Dividend Yield

0,00%

Founded

2014

Industry

Health Care

Country

Australia

Website

Paradigm Biopharmaceuticals

ISIN Number

AU000000PAR5

Website

http://www.paradigmbiopharma.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$1,47

539.13%

Last Update: 04/11/2026

Analysts: 2

Highest Price Target $2,29

Average Price Target $1,47

Lowest Price Target $0,65

In the last five quarters, Paradigm Biopharmaceuticals’s Price Target has risen from $0,22 to $0,47 - a 113,64% increase. Two analysts predict that Paradigm Biopharmaceuticals’s share price will increase in the coming year, reaching $1,47. This would represent an increase of 539,13%.

Top growth stocks in the health care sector (5Y.)

What does Paradigm Biopharmaceuticals do?

Paradigm Biopharmaceuticals Limited is a biopharmaceutical company engaged in the research and development of innovative drugs, primarily focused on addressing significant unmet medical needs. The company utilizes regulatory frameworks to facilitate its development processes and strives to enhance the quality of life through effective therapeutic solutions. Business Segments The company operates primarily within the pharmaceutical drug research and development sector. The company has been stra...

Business Segments

The company operates primarily within the pharmaceutical drug research and development sector. The company has been strategically structured into one consolidated operating segment which includes all activities related to the research and development of pharmaceutical drugs.

As part of its operational framework, the company maintains a keen emphasis on collaboration and partnership with various stakeholders, including clinical research organizations and academic institutions. This interconnectedness not only amplifies the scope of research initiatives but also increases the speed at which new therapies can potentially reach the market, benefiting patients with chronic and debilitating conditions.

Business Strategy

The company is centered on a strategic focus that prioritizes the research and development of groundbreaking pharmaceutical solutions. At the heart of this strategy is a commitment to thorough clinical research, robust regulatory compliance, and the implementation of innovative technologies that drive efficiencies in drug development processes.

Through a combination of internal research initiatives and strategic partnerships, the company is positioned to enhance its drug pipeline effectively.

Products and Services

The company’s core focus is centered around the research and development of pharmaceutical drugs. The company is dedicated to innovating solutions that address unmet medical needs, particularly in notable therapeutic areas.

The primary service provided by the company revolves around comprehensive drug development capabilities, ranging from preclinical research to advanced clinical trials.

Geographical Markets Served

The company focuses on the global pharmaceutical market, with an emphasis on reaching diverse populations through innovative drug solutions.

Customers

Paradigm Biopharmaceuticals Limited serves a diverse array of customers, primarily within the healthcare and biopharmaceutical sectors. The company’s primary clientele includes healthcare providers, research institutions, and regulatory bodies, all of whom are integral to advancing the company’s drug development initiatives.

Sales and Marketing

The company employs a multi-faceted approach to marketing and distribution that is primarily anchored in research credibility and scientific data presentation. The company's marketing efforts focus on building connections with healthcare providers, researchers, and regulatory authorities through comprehensive educational initiatives. Engagement with healthcare professionals is a critical aspect of the company's marketing strategy.

History

Paradigm Biopharmaceuticals Limited was founded in 2014. The company was incorporated in 2014.

New support ticket

Explore

Paradigm Biopharmaceuticals Stock Value

Paradigm Biopharmaceuticals Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Paradigm Biopharmaceuticals do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Paradigm Biopharmaceuticals Stock Value

Paradigm Biopharmaceuticals Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Paradigm Biopharmaceuticals do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.